Myasthenia gravis other imaging findings: Difference between revisions

	Myasthenia gravis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myasthenia Gravis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myasthenia gravis other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Myasthenia gravis other imaging findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myasthenia gravis other imaging findings
CDC on Myasthenia gravis other imaging findings
Myasthenia gravis other imaging findings in the news
Blogs on Myasthenia gravis other imaging findings
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Myasthenia gravis other imaging findings

Revision as of 18:27, 29 June 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 6: / Line 6: @@
 ==Other Imaging Findings==
-[[Immunofluorescence]] shows [[IgG]] antibodies on the neuromuscular junction. (Note that it is not the antibody which causes myasthenia gravis that fluoresces, but rather a [[secondary antibody]] directed against it.) Muscle electron microscopy shows receptor infolding and loss of the tips of the folds, together with widening of the [[Chemical synapse|synaptic]] clefts. Both these techniques are currently used for research rather than diagnostically.
 ==References==